This review will summarize the role of the NLRP3 inflammasome complex in the development of CA-CRC and summarize studies that report on the downregulation of NLRP3 activity, in order to develop therapeutic strategies in IBD as well as in CA-CRC. This evidence concerns the gene NLRP3 and inflammatory bowel disease.